EarningsAdjusted EPS of $2.58 topped Street expectations of $2.35 by $0.23, a notable 19% beat.
Financial PerformanceSTERIS's quarterly revenue of $1,279.5 million represented organic growth of approximately 5.4% year-over-year and outpaced the consensus of $1,270.0 million.
Market PositionSmaller players are stepping away from EO-based sterilization, which could serve as a tailwind for STERIS.